Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1401 of 6351
-
Which Root-End filling technique heals better?
Disease control Recruiting nowTo evaluate and compare the effect of orthograde and retrograde MTA root end filling on clinical, 2D and 3D radiographic success and quality of life after periapical surgery in posteriors- A Randomised Control Trial
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Brain cancer radiotherapy gets a precision boost from advanced MRI
Disease control Recruiting nowThis is a research study to determine if a novel molecular magnetic resonance imaging (MRI) technique, called amide proton transfer (APT) imaging, is useful in identifying the most aggressive areas of tumor needed for radiotherapy of brain tumors.
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New shot for stubborn constipation pain enters Mid-Stage trial
Symptom relief Recruiting nowThe purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated what side effects may occur, and the safety and efficacy in participants with Irritable Bowel Syndrome-Constipation (IBS-C). The study drug will be administered subcutaneously (SC) (under the s…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New hope for advanced prostate cancer: experimental drug GDC-1261 enters trials
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-1261 in participants with advanced or metastatic prostate cancer. It's also to identify a recommended dose(s) and regimen for GDC-1261 for subsequent studies.
Phase 1/2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New catheter targets pancreatic cancer tumors directly
Disease control Recruiting nowThis study is testing a new way to deliver the chemotherapy drug Gemcitabine in pancreatic tumors using the catheter Extroducer® Infusion Catheter System. The study will include patients with Locally Advanced Pancreatic Cancer that cannot be removed with surgery. Patients will r…
Phase 1/2 • Sponsor: Smartwise Sweden AB • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Experimental CAR-T therapy targets Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis is a phase I, open-label, non-randomized, multicenter, dose-escalation trial designed to evaluate the safety, tolerability, and preliminary anti-tumor activity of autologous p95HER2.CAR-TECH2Me T cells in patients with selected advanced HER2-positive (3+) cancers, including …
Phase 1 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can yoga and values training ease the stress of parenting a child with special needs?
Symptom relief Recruiting nowParents of children with special needs often experience high levels of stress and difficulties in emotional regulation, which may negatively affect both their well-being and parent-child interactions. This study aims to evaluate the effect of a Comfort Theory-based yoga and value…
Sponsor: Ankara Yildirim Beyazıt University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New portable device could bring glaucoma screening to remote areas
Diagnosis Recruiting nowThe current situation outside of large cities in lower-income countries, as described above, is suboptimal for the diagnosis of glaucoma. Doctors have no means of assessing visual fields, and as such may not be able to identify the condition until too advanced for any meaningful …
Sponsor: Buckinghamshire Healthcare NHS Trust • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Can a simple wash save a tooth that hurts?
Disease control Recruiting nowThe aim of this randomised control trial is to compare the effect of wound lavage using 2.5% Ca(OCl)₂ and 2.5% NaOCl on the outcome of partial pulpotomy in mature permanent mandibular molars with symptomatic irreversible pulpitis (SIP).Primary objective is to evaluate and compare…
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug trial targets rare, aggressive cancer subtype
Disease control Recruiting nowPhase II open label study designed to evaluate the efficacy and safety of P-Sam in patients with aggressive, solid, NOTCH mutant or p63 low (B7-H4 high) R/M ACC-I patients.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Selenium supplements may boost ulcerative colitis treatment
Disease control Recruiting nowMicronutrient deficiencies are common in ulcerative colitis (UC). Selenium deficiency is associated with worse disease outcomes including disease flares and need for surgery. Previous in vitro and in vivo studies demonstrated that selenium regulates colonic inflammation, and that…
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug aims to protect hearts after bypass surgery
Disease control Recruiting nowADR-002K is administered to heart failure patients with ischemic heart disease who undergo coronary artery bypass surgery (CABG) to investigate its efficacy and safety.
Phase 2 • Sponsor: Rohto Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Robot companions take on dementia apathy: a new hope for caregivers?
Symptom relief Recruiting nowThe goal of this trial is to learn whether home-based robotic interventions can reduce apathy in people with cognitive decline. Apathy means reduced motivation, interest, or initiative in daily life. It is a common and distressing symptom in people with mild cognitive impairment …
Sponsor: Giovanna Zamboni • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Targeted radiation and immunotherapy join forces against Hard-to-Treat lung cancer
Disease control Recruiting nowThis is a prospective, single-center, open-label investigator-initiated study designed to evaluate the safety, tolerability, radiation dosimetry, biodistribution, and preliminary antitumor activity of \[177Lu\]Lu-RTX-2358 in combination with immune checkpoint inhibitors (ICIs) in…
Early phase 1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Touch and tingle: Non-Invasive therapies take on ringing ears
Symptom relief Recruiting nowTinnitus is a common neurosensory symptom affecting 12-30% of adults and is closely associated with anxiety, sleep disturbance, and autonomic dysregulation. Current pharmacologic treatments offer limited efficacy and notable side effects, prompting interest in non-pharmacological…
Sponsor: Tzu Chi University • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
AI reads your Heart's electrical signals to catch hidden valve disease
Diagnosis Recruiting nowAoS-SEDAI study is an observational, multicenter, retrospective and prospective clinical study. This study aims to assess Willem Artificial Intelligence (AI) ability to distinguish between aortic stenosis (AS) and non-AS patients from 12-lead electrocardiogram (ECG) data.
Sponsor: Idoven 1903 S.L. • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Shorter radiation course for esophageal cancer shows promise in new trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if hypofractionation of definitive chemoradiotherapy can treat patients with locally advanced esophageal cancer. The main question it aims to answer is if this treatment is feasible and safe. We also want to investigate the toxicity, in…
Phase 2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
AI-Designed mRNA vaccine takes on advanced tumors in first human test
Vaccine Recruiting nowThis is a phase I, open-label, single-arm, single-center, dose-escalation study to evaluate the safety, tolerability, and preliminary anti-tumor efficacy of PAN-NeoVax, an artificial intelligence (AI)-designed pan-cancer neoantigen mRNA vaccine delivered via lipid nanoparticles (…
Phase 1 • Sponsor: West China Hospital • Aim: Vaccine
Last updated Jun 27, 2026 12:32 UTC
-
Virtual reality could help prevent eating disorders in At-Risk youth
Prevention Recruiting nowThe aim of this study is to evaluate the feasibility and preliminary effects of PrevED MR, a group-based preventive intervention for adolescents and young adults at risk of developing eating disorders. PrevED MR is based on dialectical behavior therapy skills and uses mixed reali…
Sponsor: Universitat Internacional de Catalunya • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
New radiation method targets tough tumors
Disease control Recruiting nowTo assess the importance of using SBRT-LATTICE-PATHY for the radiotherapy treatment of large tumors that would be considered intractable by currently used standard techniques. In this present study, the investigators will have the possibility of combining SBRT and LATTICE techniq…
Phase 2 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC